Ligand Pharmaceuticals (NASDAQ:LGND) Q3 2026 Earnings Call
Ligand Pharmaceuticals (NASDAQ:LGND) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
- Period
- Q3 2026 earnings call
- Date
- Thu, Oct 29, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/ligand-pharmaceuticals-incorporated-lgnd-q3-2026-earnings-call
Latest news releases
- NASDAQ:LGND — Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 · Thu, Oct 15, 2026
- NASDAQ:LGND — Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million · Tue, Sep 22, 2026